文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Availability of miltefosine for the treatment of kala-azar in India.

作者信息

Sundar Shyam, Murray Henry W

机构信息

Institute of Medical Sciences, Banaras Hindu University, 6 SK Gupta Nagar, Lanka, Varanasi 221-005, India.

出版信息

Bull World Health Organ. 2005 May;83(5):394-5. Epub 2005 Jun 24.

DOI:
PMID:15976883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2626237/
Abstract
摘要

相似文献

[1]
Availability of miltefosine for the treatment of kala-azar in India.

Bull World Health Organ. 2005-5

[2]
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.

J Assoc Physicians India. 2003-7

[3]
Oral miltefosine in the treatment of kala-azar.

Natl Med J India. 2000

[4]
Treatment of leishmaniasis with miltefosine: 2008 status.

Expert Opin Drug Metab Toxicol. 2008-9

[5]
Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.

Am J Trop Med Hyg. 2009-3

[6]
Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases.

Int J Dermatol. 2010-5

[7]
Breakthrough in the management of visceral leishmaniasis.

J Assoc Physicians India. 2003-7

[8]
Oral miltefosine in the treatment of post-kala-azar dermal leishmaniasis.

Clin Exp Dermatol. 2008-1

[9]
Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.

Future Microbiol. 2010-9

[10]
Kala-azar--progress against a neglected disease.

N Engl J Med. 2002-11-28

引用本文的文献

[1]
Finishing the task of eliminating neglected tropical diseases (NTDs) in WHO South-East Asia Region: promises kept, challenges, and the way forward.

Lancet Reg Health Southeast Asia. 2023-10-29

[2]
TCP1γ Subunit Is Indispensable for Growth and Infectivity of Leishmania donovani.

Antimicrob Agents Chemother. 2020-7-22

[3]
Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani.

Pathog Dis. 2019-8-1

[4]
Enhancement Effect of Shark Cartilage Extract on Treatment of with Artemisinin and Glucantime and Evaluation of killing Factors and Apoptosis Condition.

Iran J Pharm Res. 2019

[5]
Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice.

Iran J Basic Med Sci. 2019-2

[6]
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.

Clin Microbiol Rev. 2018-8-29

[7]
Antileishmanial Activity of Amphotericin B-loaded-PLGA Nanoparticles: An Overview.

Materials (Basel). 2018-7-9

[8]
Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most.

BMJ Glob Health. 2018-5-3

[9]
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.

Parasit Vectors. 2017-1-31

[10]
Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.

Antimicrob Agents Chemother. 2017-2-23

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索